Last reviewed · How we verify
NCT03224754
Atypia of Undetermined Significance (AUS) / Follicular Lesion of Undetermined Significance (FLUS)
trial testing Determination of risk of malignancy of these thyroid lesions in Diagnoses Disease. Withdrawn.
2 May 2018
Quick facts
| Lead sponsor | University of Mississippi Medical Center |
|---|---|
| Status | Withdrawn |
| Study type | OBSERVATIONAL |
| Start date | 18 July 2017 |
| Primary completion | 2 May 2018 |
| Estimated completion | 2 May 2018 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Determination of risk of malignancy of these thyroid lesions
Conditions studied
- Diagnoses Disease — all drugs for Diagnoses Disease →
Sponsor
University of Mississippi Medical Center
Who can join
Eligibility, any sex, with Diagnoses Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
According to the guidelines for reporting thyroid fine needle aspirations known as The Bethesda System, the category of atypical cells known as AUS/ FLUS category has an estimated rate of 5 to 15% for malignancy. This study aims to determine the rate of malignancy of this category in our institution and to evaluate the clinical outcome of the participants.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03224754
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diagnoses Disease
Currently open trials in the same condition.
- NCT06439901 — Optimizing Bronchopulmonary Cancer Screening · NA · recruiting
- NCT04536220 — Establish Diagnostic Models Based on Portal Venous Blood for Pancreatic Cancer · recruiting
- NCT04567368 — TB-CAPT MTB/XDR Study · active not recruiting
- NCT06616506 — Artificial Intelligence for Highly Myopic Cataract · recruiting
Other University of Mississippi Medical Center trials
Trials by the same sponsor.
- NCT07431619 — A Web-Based Text Messaging for Tobacco Cessation in Rural Mississippi · NA · not yet recruiting
- NCT07461662 — Evaluation of Endobronchial Ultrasound Needle Cleaning Techniques and Their Impact on Specimen Contamination · NA · not yet recruiting
- NCT06216925 — Teen Mom Study: A Confirmatory Pragmatic Cluster RCT · NA · not yet recruiting
- NCT06973642 — Evaluation of Home-based Telerehabilitation Platform to Augment Orthopedic Rehabilitation · NA · recruiting
- NCT07071064 — Mississippi Community Engagement Alliance (MS CEAL): Fostering Community Solutions · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03224754 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Mississippi Medical Center
- Last refreshed: 11 May 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03224754.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing